21st.Bio Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 61

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $97M

  • Investors
  • 1

21st.Bio General Information

Description

Developer of a biological platform designed to focus on scaling up the manufacture of proteins and peptides. The company's platform develops large-scale production of molecules through diverse expressions like fungi, yeast, or bacteria, enabling businesses in the food, agriculture, and energy industries to access sustainable products at competitive costs and quantities.

Contact Information

Website
www.21st.bio
Formerly Known As
Copenhagen Bio Partners
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Sydmarken 42
  • 2860 Søborg
  • Denmark
+45 32
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • Sydmarken 42
  • 2860 Søborg
  • Denmark
+45 32

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

21st.Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 21-Dec-2021 $97M Completed Generating Revenue
To view 21st.Bio’s complete valuation and funding history, request access »

21st.Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

21st.Bio Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Novo Holdings Venture Capital Minority
To view 21st.Bio’s complete investors history, request access »

21st.Bio Investments (1)

21st.Bio’s most recent deal was a Later Stage VC with Reshape Biotech for . The deal was made on 09-Apr-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Reshape Biotech 09-Apr-2024 Later Stage VC Other Healthcare Technology Systems
To view 21st.Bio’s complete investments history, request access »

21st.Bio FAQs

  • When was 21st.Bio founded?

    21st.Bio was founded in 2020.

  • Where is 21st.Bio headquartered?

    21st.Bio is headquartered in Søborg, Denmark.

  • What is the size of 21st.Bio?

    21st.Bio has 61 total employees.

  • What industry is 21st.Bio in?

    21st.Bio’s primary industry is Biotechnology.

  • Is 21st.Bio a private or public company?

    21st.Bio is a Private company.

  • What is 21st.Bio’s current revenue?

    The current revenue for 21st.Bio is .

  • How much funding has 21st.Bio raised over time?

    21st.Bio has raised $97M.

  • Who are 21st.Bio’s investors?

    Novo Holdings has invested in 21st.Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process